Inverted Formin 2 (INF2)

[Edit]

C14orf151; C14orf173; HBEBP2-binding protein C; Inverted Formin,FH2 And WH2 Domain Containing

Inverted Formin 2 (INF2)
Actin filaments grow only when actin monomers have access to the fast-growing barbed end of the filament. The geometry of the filament network depends on the actions of the ARP2/3 complex and members of the formin family, such as INF2. The ARP2/3 complex binds to the sides of preexisting filaments and nucleates filaments whose barbed ends are quickly blocked by capping proteins, producing brush-like structures, such as those found at the leading edges of crawling cells. In contrast, formins bind to the barbed ends of growing filaments and protect them from capping, creating long filaments that can be cross-linked into bundles, such as those found in actin cables of yeast. Interaction of formins with actin barbed ends occurs through the formin homology-2 (FH2) domain.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Inverted Formin 2 (INF2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Inverted Formin 2 (INF2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Inverted Formin 2 (INF2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Inverted Formin 2 (INF2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Inverted Formin 2 (INF2) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Inverted Formin 2 (INF2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Inverted Formin 2 (INF2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Inverted Formin 2 (INF2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Inverted Formin 2 (INF2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Inverted Formin 2 (INF2) ELISA Kit Customized Service Offer
  1. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  2. "The DNA sequence and analysis of human chromosome 14." Nature 421:601-607(2003) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. , Submitted (JUL-2007) to UniProtKB
  5. "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
  6. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
  7. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  8. "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography."Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract]
  9. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  10. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  11. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  12. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  13. "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]
  14. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  15. "Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis."Nat. Genet. 42:72-76(2010) [PubMed] [Europe PMC] [Abstract]
  16. "Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis." J. Am. Soc. Nephrol. 22:239-245(2011) [PubMed] [Europe PMC] [Abstract]
  17. "INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy." N. Engl. J. Med. 365:2377-2388(2011) [PubMed] [Europe PMC] [Abstract]
  18. "A novel mutation, outside of the candidate region for diagnosis, in the inverted formin 2 gene can cause focal segmental glomerulosclerosis."Kidney Int. 83:153-159(2013) [PubMed] [Europe PMC] [Abstract]
  19. "Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis."Kidney Int. 81:94-99(2012) [PubMed] [Europe PMC] [Abstract]